$PTCT

Only if $PTCT Stu Peltz has the same skill to convince the street in his ability to "communicate" with the FDA authorities - .. this is study 41 - the 3rd P3 they did in DMD - https://t.co/et5cEsU4Lv - data came out in June 2022 - .. they missed the primary then as usual they dug the whole set - and found - holy crap - ONLY IF they had done the ITT as the pre-spec primary - they would have .. but no, they did the primary of a specific population they "expect" to enrich the data delta outcome - then backfired - .. this is the subcut they did with the ITT - .. To this date, the FDA has yet to greenlight a review of this study, and the CHMP over EMA said this trial, along with the other trials DO NOT support the ongoing conditional approval of Translarna in Europe - the only meds for the